Witryna6 kwi 2024 · BackgroundImmune checkpoint inhibitors (ICIs) have revolutionized cancer therapy in the past decade and amplify T-cell-mediated immune responses by disrupting immunoinhibitory signals. The augmented T-cell immune response has led to a range of immune-related adverse effects (irAEs). Immune-related cardiotoxicity has been … WitrynaICI-related cardiotoxicity is uncommon but critical with a high mortality rate and poor prognosis, especially for a small group of patients with symptomatic cardiac abnormalities, which should be given baseline examinations and biochemical analyses before and after the initiation of immunotherapy. Background Immune checkpoint …
Position Statement on the management of the immune checkpoint …
Witryna14 kwi 2024 · Abstract. The low overall survival rates of breast cancer (BC) patients in sub-Saharan Africa (SSA) are driven by regionally differing tumor biology, advanced tumor stages at diagnosis and limited access to therapy. However, it is not known whether regional differences in the composition of the tumor microenvironment (TME) … Witryna14 kwi 2024 · We aimed to evaluate the predictive and prognostic value of baseline 18F-FDG-PET-CT (PET-CT) radiomic features (RFs) for immune checkpoint-inhibitor … sharepoint management shell 2013
Clinical characteristics and management of immune checkpoint …
Witryna3 sty 2024 · Ongoing trials are evaluating immune checkpoint inhibitors—used alone, in combination with cytotoxic, targeted, radiation therapies, or with other such inhibitors—for therapy in patients with advanced bladder cancer. Fed … Witryna10 mar 2024 · Review Article 01 April 2024. ... Review Article 26 January 2024. Immune-checkpoint inhibitors: long-term implications of toxicity. Immune … WitrynaIntroduction. Immune function is governed in part by a complex array of stimulatory and inhibitory cell-surface interactions. A coordinated cancer immunity cascade must … sharepoint management shell module